Urooncology

THE ROLE OF PROPHYLACTIC TAMSULOSIN (FLOMAX®) ± DEXAMETHASONE IN PATIENTS UNDERGOING PROSTATE I125 SEED IMPLANTS FOR PROSTATE CARCINOMA: A RANDOMIZED DOUBLE-BLIND STUDY

Volume 34 · Issue 3 Publish Date: July 25, 2019
Thomas P. CARLSON Andrew ALTMAN Nabil CHEHADE Kenneth ANGERMEIER James ULCHAKER Chandana A. REDDY Mohamed ELSHAIKH Jay P. CIEZKI Mustafa KAPLAN Eric A. KLEIN
Full Text PDF

Published In

Urology Research & Practice

Volume 34 · Issue 3

Pages: 285-290

History

Published Online: July 25, 2019

Copyright © 2008 Urology Research and Practice

Thomas P. CARLSON
Department of Radiation Oncology, The Cleveland Clinic Foundation, Cleveland, OH, USA
Andrew ALTMAN
Department of Urology, Kaiser Permanente, Cleveland, OH, USA
Nabil CHEHADE
Department of Urology, Kaiser Permanente, Cleveland, OH, USA
Kenneth ANGERMEIER
Glickman Urological Institute, The Cleveland Clinic Foundation, Cleveland, OH, USA
James ULCHAKER
Glickman Urological Institute, The Cleveland Clinic Foundation, Cleveland, OH, USA
Chandana A. REDDY
Department of Radiation Oncology, The Cleveland Clinic Foundation, Cleveland, OH, USA
Mohamed ELSHAIKH
Department of Radiation Oncology, University of Michigan, MI, USA
Jay P. CIEZKI
Department of Radiation Oncology, The Cleveland Clinic Foundation, Cleveland, OH, USA
Mustafa KAPLAN
Department of Urology, University of Trakya, EDIRNE, TURKEY
Eric A. KLEIN
Glickman Urological Institute, The Cleveland Clinic Foundation, Cleveland, OH, USA
Full Text Full Text PDF

Abstract

-

Similar Articles

Article Info
Published In
Journal Urology Research & Practice
Volume / Issue Volume 34 · Issue 3
Pages 285-290
History
Published Online July 25, 2019
Copyright
Copyright (c) 2008 Urology Research and Practice
Affiliations
Thomas P. CARLSON
Department of Radiation Oncology, The Cleveland Clinic Foundation, Cleveland, OH, USA
Andrew ALTMAN
Department of Urology, Kaiser Permanente, Cleveland, OH, USA
Nabil CHEHADE
Department of Urology, Kaiser Permanente, Cleveland, OH, USA
Kenneth ANGERMEIER
Glickman Urological Institute, The Cleveland Clinic Foundation, Cleveland, OH, USA
James ULCHAKER
Glickman Urological Institute, The Cleveland Clinic Foundation, Cleveland, OH, USA
Chandana A. REDDY
Department of Radiation Oncology, The Cleveland Clinic Foundation, Cleveland, OH, USA
Mohamed ELSHAIKH
Department of Radiation Oncology, University of Michigan, MI, USA
Jay P. CIEZKI
Department of Radiation Oncology, The Cleveland Clinic Foundation, Cleveland, OH, USA
Mustafa KAPLAN
Department of Urology, University of Trakya, EDIRNE, TURKEY
Eric A. KLEIN
Glickman Urological Institute, The Cleveland Clinic Foundation, Cleveland, OH, USA
Cite this Article
Outlines